|
⚲
|
| Keyboard |
| McCullough David
✚
|
|
|---|---|
| CIK # | 0001395238 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001395238] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McCullough David | |
| Biocryst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-03-15 | Grant | 15,505 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-03-15 | Tax withheld | 5,307 | $5.23 | 27,756 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-03-02 | Sell | 574 | $4.78 | 2,744 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-03-01 | Grant | 8,500 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2012-03-01 | Grant | 50,000 | $4.73 | 236,500 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-01-03 | Option exercise | 60,624 | $1.20 | 72,749 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2012-01-03 | Option exercise | 60,624 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2012-01-03 | Sell | 60,624 | $2.45 | 148,529 |